Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
- 1 January 2003
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 45 (1) , 1-36
- https://doi.org/10.1016/s1040-8428(02)00078-1
Abstract
No abstract availableKeywords
This publication has 370 references indexed in Scilit:
- LMP1 structure and signal transductionSeminars in Cancer Biology, 2001
- Epstein-Barr virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-κB and different signaling pathwaysJournal of Molecular Biology, 2001
- Malignant transformation of B lymphoma cell line BJAB by Epstein–Barr virus‐encoded small RNAsFEBS Letters, 2000
- The multistep nature of cancerTrends in Genetics, 1993
- Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell deathCell, 1991
- Circulating Epstein-Barr virus-carrying B cells in acute malariaThe Lancet, 1991
- Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocationCell, 1986
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cellsCell, 1985
- Characteristic chromosomal abnormalities in biopsies and lymphoid‐cell lines from patients with burkitt and non‐burkitt lymphomasInternational Journal of Cancer, 1976
- Malignant lymphoma in African children.I. A clinical syndromeCancer, 1961